$46.52
-0.40-0.85%
At close: -
$46.52
0.000.00%
After Hours: Jan 17, 4:00 PM EDT
Comments
Loading...
Tarsus Pharmaceuticals (TARS) Forecast
NewsEarningsTarsus Pharmaceuticals (TARS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestTarsus Pharmaceuticals (NASDAQ:TARS) Stock Quotes, Forecast and News Summary
Tarsus Pharmaceuticals Stock (NASDAQ: TARS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Tarsus Pharmaceuticals (TARS) stock?
You can purchase shares of Tarsus Pharmaceuticals (NASDAQ:TARS) through any online brokerage.
Who are Tarsus Pharmaceuticals (TARS) competitors?
Other companies in Tarsus Pharmaceuticals’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), ANI Pharmaceuticals (NASDAQ:ANIP) and Axsome Therapeutics (NASDAQ:AXSM).
What is the forecast, or price target, for Tarsus Pharmaceuticals (TARS) stock?
Tarsus Pharmaceuticals has a consensus price target of $52.00.
What is the current price for Tarsus Pharmaceuticals (TARS)?
The stock price for Tarsus Pharmaceuticals (NASDAQ: TARS) is $46.52 last updated January 17, 2025 at 4:00 PM EST.
Does Tarsus Pharmaceuticals (TARS) pay a dividend?
There are no upcoming dividends for Tarsus Pharmaceuticals.
When is Tarsus Pharmaceuticals (NASDAQ:TARS) reporting earnings?
Tarsus Pharmaceuticals’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
Is Tarsus Pharmaceuticals (TARS) going to split?
There is no upcoming split for Tarsus Pharmaceuticals.
What sector and industry does Tarsus Pharmaceuticals (TARS) operate in?
Tarsus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.